Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Filip Krag Knop

Showing results (51-60 of 98) with videos related to

Pageof 10
Sort By:
Journal of the American Academy of Dermatology|March 2, 2024
Effects of oral roflumilast therapy on body weight and cardiometabolic parameters in patients with psoriasis - results from a randomized controlled trial (PSORRO)Mette Gyldenløve, Jennifer Astrup Sørensen, Simon Fage, et al.
The Journal of Clinical Endocrinology and Metabolism|December 4, 2008
KATP channel closure ameliorates the impaired insulinotropic effect of glucose-dependent insulinotropic polypeptide in patients with type 2 diabetesKasper Aaboe, Filip Krag Knop, Tina Vilsboll, et al.
Ugeskrift for Laeger|March 18, 2014
[Gut microbiota may have influence on glucose and lipid metabolism]Kristian Hallundbæk Mikkelsen, Morten Frost Nielsen, Michael Tvede, et al.
Diabetes, Obesity & Metabolism|March 18, 2025
Efficacy and safety of continuous glucose monitoring on glycaemic control in patients with chronic pancreatitis and insulin-treated diabetes: A randomised, open-label, crossover trialLine Davidsen, Simon Lebech Cichosz, Peter Bisgaard Stæhr, et al.
Gut|April 18, 2023
Serum lipidome unravels a diagnostic potential in bile acid diarrhoeaMonika Lewinska, Martin Lund Kårhus, Anne-Marie Gade Ellegaard, et al.
Journal of Diabetes Science and Technology|July 19, 2025
Increased Glycemic Variability in Patients With Chronic Pancreatitis and Diabetes Compared to Type 2 DiabetesLine Davidsen, Morten Hasselstrøm Jensen, Thomas Kronborg, et al.
Gut|August 13, 2025
Mucosal transcriptomic landscape along the small and large intestines in individuals with and without type 2 diabetesHannah Gilliam-Vigh, Anne Marie Ellegaard, Martin Rønn Madsen, et al.
Diabetes, Obesity & Metabolism|April 3, 2020
Use of inhaled corticosteroids and the risk of developing type 2 diabetes in patients with chronic obstructive pulmonary diseaseMohamad Isam Saeed, Josefin Eklöf, Imane Achir, et al.
The Journal of Clinical Endocrinology and Metabolism|March 23, 2016
Cholecystokinin-Induced Gallbladder Emptying and Metformin Elicit Additive Glucagon-Like Peptide-1 ResponsesUlrich Rohde, David Peick Sonne, Mikkel Christensen, et al.
BMJ Open|April 4, 2015
Efficacy and safety of the glucagon-like peptide-1 receptor agonist liraglutide added to insulin therapy in poorly regulated patients with type 1 diabetes--a protocol for a randomised, double-blind, placebo-controlled study: the Lira-1 studyThomas Fremming Dejgaard, Filip Krag Knop, Lise Tarnow, et al.
Pageof 10

Showing results (51-60 of 98) with videos related to

Sort By:
Pageof 10
Journal of the American Academy of Dermatology|March 2, 2024
Effects of oral roflumilast therapy on body weight and cardiometabolic parameters in patients with psoriasis - results from a randomized controlled trial (PSORRO)Mette Gyldenløve, Jennifer Astrup Sørensen, Simon Fage, et al.
The Journal of Clinical Endocrinology and Metabolism|December 4, 2008
KATP channel closure ameliorates the impaired insulinotropic effect of glucose-dependent insulinotropic polypeptide in patients with type 2 diabetesKasper Aaboe, Filip Krag Knop, Tina Vilsboll, et al.
Ugeskrift for Laeger|March 18, 2014
[Gut microbiota may have influence on glucose and lipid metabolism]Kristian Hallundbæk Mikkelsen, Morten Frost Nielsen, Michael Tvede, et al.
Diabetes, Obesity & Metabolism|March 18, 2025
Efficacy and safety of continuous glucose monitoring on glycaemic control in patients with chronic pancreatitis and insulin-treated diabetes: A randomised, open-label, crossover trialLine Davidsen, Simon Lebech Cichosz, Peter Bisgaard Stæhr, et al.
Gut|April 18, 2023
Serum lipidome unravels a diagnostic potential in bile acid diarrhoeaMonika Lewinska, Martin Lund Kårhus, Anne-Marie Gade Ellegaard, et al.
Journal of Diabetes Science and Technology|July 19, 2025
Increased Glycemic Variability in Patients With Chronic Pancreatitis and Diabetes Compared to Type 2 DiabetesLine Davidsen, Morten Hasselstrøm Jensen, Thomas Kronborg, et al.
Gut|August 13, 2025
Mucosal transcriptomic landscape along the small and large intestines in individuals with and without type 2 diabetesHannah Gilliam-Vigh, Anne Marie Ellegaard, Martin Rønn Madsen, et al.
Diabetes, Obesity & Metabolism|April 3, 2020
Use of inhaled corticosteroids and the risk of developing type 2 diabetes in patients with chronic obstructive pulmonary diseaseMohamad Isam Saeed, Josefin Eklöf, Imane Achir, et al.
The Journal of Clinical Endocrinology and Metabolism|March 23, 2016
Cholecystokinin-Induced Gallbladder Emptying and Metformin Elicit Additive Glucagon-Like Peptide-1 ResponsesUlrich Rohde, David Peick Sonne, Mikkel Christensen, et al.
BMJ Open|April 4, 2015
Efficacy and safety of the glucagon-like peptide-1 receptor agonist liraglutide added to insulin therapy in poorly regulated patients with type 1 diabetes--a protocol for a randomised, double-blind, placebo-controlled study: the Lira-1 studyThomas Fremming Dejgaard, Filip Krag Knop, Lise Tarnow, et al.
Pageof 10